DOLORES LOPEZ-TERRADA to Liver Neoplasms
This is a "connection" page, showing publications DOLORES LOPEZ-TERRADA has written about Liver Neoplasms.
Connection Strength
5.041
-
"Update on pediatric primary liver tumors". Virchows Arch. 2025 Jan; 486(1):23-47.
Score: 0.454
-
Evaluation of the diagnostic biopsy approach for children with hepatoblastoma: A report from the children's oncology group AHEP 0731 liver tumor committee. J Pediatr Surg. 2020 Apr; 55(4):655-659.
Score: 0.306
-
Predisposing Conditions to Pediatric Hepatocellular Carcinoma and Association With Outcomes: Single-center Experience. J Pediatr Gastroenterol Nutr. 2019 05; 68(5):695-699.
Score: 0.305
-
Characterization of pediatric hepatocellular carcinoma reveals genomic heterogeneity and diverse signaling pathway activation. Pediatr Blood Cancer. 2019 07; 66(7):e27745.
Score: 0.304
-
Hepatoblastoma in patients with molecularly proven familial adenomatous polyposis: Clinical characteristics and rationale for surveillance screening. Pediatr Blood Cancer. 2018 08; 65(8):e27103.
Score: 0.285
-
Acquisition of Cholangiocarcinoma Traits during Advanced Hepatocellular Carcinoma Development in Mice. Am J Pathol. 2018 03; 188(3):656-671.
Score: 0.278
-
Genomic analysis of hepatoblastoma identifies distinct molecular and prognostic subgroups. Hepatology. 2017 01; 65(1):104-121.
Score: 0.258
-
Multi-organ Mapping of Cancer Risk. Cell. 2016 Aug 25; 166(5):1132-1146.e7.
Score: 0.254
-
Novel patient-derived xenograft and cell line models for therapeutic testing of pediatric liver cancer. J Hepatol. 2016 08; 65(2):325-33.
Score: 0.248
-
Current issues and controversies in the classification of pediatric hepatocellular tumors. Pediatr Blood Cancer. 2012 Nov; 59(5):780-4.
Score: 0.189
-
Mutations of PTCH1, MLL2, and MLL3 are not frequent events in hepatoblastoma. Pediatr Blood Cancer. 2012 Jun; 58(6):1006-7.
Score: 0.183
-
Hep G2 is a hepatoblastoma-derived cell line. Hum Pathol. 2009 Oct; 40(10):1512-5.
Score: 0.157
-
Histologic subtypes of hepatoblastoma are characterized by differential canonical Wnt and Notch pathway activation in DLK+ precursors. Hum Pathol. 2009 Jun; 40(6):783-94.
Score: 0.150
-
Hepatoblastoma. Nat Rev Dis Primers. 2025 May 22; 11(1):36.
Score: 0.116
-
An indocyanine green-based liquid biopsy test for circulating tumor cells for pediatric liver cancer. Hepatol Commun. 2024 06 01; 8(6).
Score: 0.108
-
Histopathologic and immunophenotypic characterization of patient-derived pediatric malignant hepatocellular tumor xenografts (PDXs). Pathol Res Pract. 2024 Mar; 255:155163.
Score: 0.106
-
Comparative Clinicopathologic and Genomic Analysis of Hepatocellular Neoplasm, Not Otherwise Specified, and Hepatoblastoma. Mod Pathol. 2024 Feb; 37(2):100385.
Score: 0.105
-
Circadian dysfunction induces NAFLD-related human liver cancer in a mouse model. J Hepatol. 2024 02; 80(2):282-292.
Score: 0.104
-
Surgical Management and Outcomes of Patients with Multifocal Hepatoblastoma. J Pediatr Surg. 2023 Sep; 58(9):1715-1726.
Score: 0.101
-
HepT1-derived murine models of high-risk hepatoblastoma display vascular invasion, metastasis, and circulating tumor cells. Biol Open. 2022 09 15; 11(9).
Score: 0.096
-
?-catenin cancer-enhancing genomic regions axis is involved in the development of fibrolamellar hepatocellular carcinoma. Hepatol Commun. 2022 10; 6(10):2950-2963.
Score: 0.096
-
Small Cell Undifferentiated Histology Does Not Adversely Affect Outcome in Hepatoblastoma: A Report From the Children's Oncology Group (COG) AHEP0731 Study Committee. J Clin Oncol. 2022 02 10; 40(5):459-467.
Score: 0.091
-
Transarterial Radioembolization Treatment as a Bridge to Surgical Resection in Pediatric Hepatocellular Carcinoma. J Pediatr Hematol Oncol. 2021 Nov 01; 43(8):e1181-e1185.
Score: 0.091
-
The importance of age as prognostic factor for the outcome of patients with hepatoblastoma: Analysis from the Children's Hepatic tumors International Collaboration (CHIC) database. Pediatr Blood Cancer. 2020 08; 67(8):e28350.
Score: 0.082
-
Hepatoblastoma and Pediatric Hepatocellular Carcinoma: An Update. Pediatr Dev Pathol. 2020 Mar-Apr; 23(2):79-95.
Score: 0.078
-
Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children's Hepatic tumors International Collaboration. Lancet Oncol. 2017 01; 18(1):122-131.
Score: 0.064
-
Reply to R. Dong et al. J Clin Oncol. 2017 01; 35(1):116-117.
Score: 0.064
-
Hepatoblastoma modeling in mice places Nrf2 within a cancer field established by mutant ?-catenin. JCI Insight. 2016 Oct 06; 1(16):e88549.
Score: 0.064
-
P2X3 purinergic receptor overexpression is associated with poor recurrence-free survival in hepatocellular carcinoma patients. Oncotarget. 2015 Dec 01; 6(38):41162-79.
Score: 0.060
-
The Children's Hepatic tumors International Collaboration (CHIC): Novel global rare tumor database yields new prognostic factors in hepatoblastoma and becomes a research model. Eur J Cancer. 2016 Jan; 52:92-101.
Score: 0.060
-
Hepatoblastoma state of the art: pathology, genetics, risk stratification, and chemotherapy. Curr Opin Pediatr. 2014 Feb; 26(1):19-28.
Score: 0.053
-
Towards an international pediatric liver tumor consensus classification: proceedings of the Los Angeles COG liver tumors symposium. Mod Pathol. 2014 Mar; 27(3):472-91.
Score: 0.052
-
Protocol for the examination of specimens from pediatric patients with hepatoblastoma. Arch Pathol Lab Med. 2007 Apr; 131(4):520-9.
Score: 0.033
-
FOXG1 is overexpressed in hepatoblastoma. Hum Pathol. 2007 Mar; 38(3):400-9.
Score: 0.033
-
Lymphoproliferative disorders in Costa Rica and simian virus 40. Haematologica. 2005 Dec; 90(12):1635-42.
Score: 0.008
-
Donor origin of posttransplant lymphoproliferative disorder localized to a liver allograft: demonstration by fluorescence in situ hybridization. Arch Pathol Lab Med. 1997 Jul; 121(7):701-6.
Score: 0.004